Pura Vida Investments’s Lipocine LPCN Stock Holding History

Pura Vida Investments’s Portfolio LPCN Stock Details LPCN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,220	Closed	-$77K	–	307
2021 Q2	$77K	Buy	+3,220	New	+$75.7K	﹤0.01%	215

Other funds holding LPCN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Pura Vida Investments's LPCN Position: Q3 2021 in Review

Pura Vida Investments sold out of Lipocine (LPCN) in Q3 2021, closing a stake of 3,220 shares — an estimated $77K sold.

Pura Vida Investments first reported a position in LPCN in Q2 2021 and held it in 1 quarter. The position peaked at $77K in Q2 2021. 38 funds tracked by Wall St. Rank hold LPCN as of Q3 2021.

Pura Vida Investments reported no remaining Lipocine position as of Q3 2021 after selling out during the quarter.
Pura Vida Investments sold 3,220 Lipocine shares in Q3 2021, an estimated $77K.
Pura Vida Investments first reported a position in Lipocine in Q2 2021 and held it in 1 quarter.
Pura Vida Investments's Lipocine position peaked at $77K in Q2 2021.
38 funds tracked by Wall St. Rank held Lipocine as of Q3 2021.

Based on Pura Vida Investments's 13F filing for Q3 2021, filed 15 Nov 2021.